These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2474220)

  • 1. [Changes of the blood kallikrein-kinin system in patients with diffuse toxic goiter under the influence of thyrostatic therapy and prodectin].
    Matiashina GI
    Vrach Delo; 1989 Apr; (4):31-3. PubMed ID: 2474220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of prodectin on the activity of the blood kallikrein-kinin system in diffuse toxic goiter].
    Oleĭnik VA; Matiashina GI
    Probl Endokrinol (Mosk); 1986; 32(4):7-10. PubMed ID: 3639497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma kinin system indices in diabetes mellitus patients before and after treatment with prodectin].
    Spesivtseva VG; Men'shikov VV; Beliakov NV; Mamaeva GG; Stepanova NI
    Probl Endokrinol (Mosk); 1978; 24(6):19-22. PubMed ID: 724671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Activity of the kallikrein-kinin system in patients with ischemic heart disease treated with parmidine].
    Vygovskiĭ VP; Zaremba EF; Podil'chak EM; Dutka RIa; Gorgota OV
    Vrach Delo; 1985 Sep; (9):6-8. PubMed ID: 2416131
    [No Abstract]   [Full Text] [Related]  

  • 5. [Several aspects of the pathogenesis of disturbances of hemostasis in patients with diffuse toxic goiter].
    Oleĭnik VA; Matiashina GI
    Ter Arkh; 1988; 60(9):43-6. PubMed ID: 3217879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of combined therapy with the use of thymalin and piracetam on the level of middle-molecule peptides in the blood and on the lipid peroxidation activity in patients with diffuse toxic goiter].
    Iangolenko VV
    Ter Arkh; 1991; 63(10):60-3. PubMed ID: 1725225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activation of the kallikrein-kinin system of the blood in hypertension and atherosclerosis with transient cerebral circulatory disorders].
    Vizir AD; Kechin IL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(8):1152-4. PubMed ID: 6208710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recurrence rate following thyrostatic therapy of patients with hyperthyroidism and diffuse goiter (Graves' disease). Relation to the concentration of inorganic iodine in the plasma].
    Hansen PE
    Ugeskr Laeger; 1983 Mar; 145(13):980-2. PubMed ID: 6190284
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of the antikinin preparation prodectin in the complex treatment of pulmonary tuberculosis patients].
    Keleberda KIa; Svistunova AS; Kaminskaia GO; Kordonskaia VM
    Probl Tuberk; 1982 Oct; (10):42-5. PubMed ID: 7178102
    [No Abstract]   [Full Text] [Related]  

  • 10. [State of the kallikrein-kinin system components in rheumatism and their dynamics under the influence of treatment].
    Temirova KV; Nosova VF; Kel'manson AIu
    Vopr Revm; 1978; (4):43-6. PubMed ID: 364834
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of reinfusion of UV-irradiated blood on the activity of the kallikrein-kinin system in patients with diffuse phlegmons of the face and neck].
    Karandashov VN; Chirkova LD; Petukhov EB
    Vestn Khir Im I I Grek; 1988 Apr; 140(4):106-10. PubMed ID: 2458652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Amino acid composition of the blood in patients with diffuse toxic goiter during conservative therapy].
    Borodina LV
    Ter Arkh; 1987; 59(6):100-3. PubMed ID: 3629484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Osteocalcin in diffuse toxic goiter].
    Balabolkin MI; Khaiutina TL; Mkrtumian AM
    Ross Med Zh; 1992; (1):13-5. PubMed ID: 1377070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intensity of kininergic reactions of the cardiovascular system in different activities of the plasma kallikrein-kinin system].
    Kiselev VI; Lebedev NM
    Fiziol Zh SSSR Im I M Sechenova; 1983 Mar; 69(3):386-90. PubMed ID: 6552214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prodectin in the treatment of viral hepatitis].
    Kozhukhova EA; Iakushin AI; Zakharova VI; Mebel' BD; Larionov GM
    Sov Med; 1983; (10):96-7. PubMed ID: 6658556
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of trypsin and heparin electrophoresis on the state of the kallikrein-kinin system in hypertension].
    Bogutskii BV; Karpitskii VV; Leshchinskaia NP; Guz SIa
    Vopr Kurortol Fizioter Lech Fiz Kult; 1979; (3):43-6. PubMed ID: 382620
    [No Abstract]   [Full Text] [Related]  

  • 17. [Indices of the blood kallikrein-kinin and coagulating systems in hypertension patients during treatment].
    Zholob VM; Vygovskiĭ VP
    Klin Med (Mosk); 1985 Jan; 63(1):74-8. PubMed ID: 3846006
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of antiadrenergic and myotropic hypotensive agents on the blood kallikrein-kinin system in experimental hypertension].
    Abdullina RN; Davidenko IuD; Fridman SM; Zaripova GR; Didenko RG
    Farmakol Toksikol; 1988; 51(3):38-41. PubMed ID: 3410023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of taktivin and levamisole in the combined treatment of diffuse toxic goiter].
    Balabolkin MI; Arion VIa; Petunina NA
    Sov Med; 1987; (12):32-5. PubMed ID: 3502197
    [No Abstract]   [Full Text] [Related]  

  • 20. [The activity of the blood kallikrein-kinin system as a criterion of the severity of appendicular peritonitis in children].
    Ormantaev KS; Arynov NM
    Vestn Khir Im I I Grek; 1991 Apr; 146(4):79-81. PubMed ID: 1661963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.